Loading...
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
The fact that over 30% of current pharmaceuticals target heptahelical G protein–coupled receptors (GPCRs) attests to their tractability as drug targets. Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate phys...
Na minha lista:
| Udgivet i: | Mol Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4551052/ https://ncbi.nlm.nih.gov/pubmed/26134495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.099630 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|